文献速递肝病

胆汁酸转运蛋白基因的组蛋白乙酰化在肝硬化中起关键作用

Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis.
PubMed 文献 · J Hepatol · 2021-12-25

研究利用肝细胞特异性敲除MCRS1的小鼠模型,结合细胞实验、人类样本及多组学方法,揭示MCRS1缺失通过增加胆汁酸转运蛋白基因组蛋白乙酰化、下调NTCP、使胆汁酸在肝窦聚集并激活肝星状细胞FXR,从而促进肝硬化。

要点

  • 肝细胞MCRS1缺失下调NTCP,使胆汁酸在肝窦聚集并激活肝星状细胞FXR。
  • 小鼠重新表达NTCP可减轻肝硬化,肝星状细胞敲除FXR可抑制纤维化标志。
  • 人肝硬化肝脏显示核MCRS1和NTCP表达降低。

核心结论

  • MCRS1作为组蛋白乙酰化调节因子维持基因表达和肝脏稳态,其缺失诱导胆汁酸转运蛋白基因乙酰化、胆汁酸流紊乱及肝星状细胞FXR激活,该轴是肝硬化中核心且通用的信号事件,对肝硬化治疗有重要意义。

研究设计与样本

  • 研究使用肝细胞特异性消除MCRS1的小鼠遗传模型,并结合其他小鼠模型、细胞培养和人类样本,采用定量蛋白质组学、单核/单细胞RNA测序和染色质免疫沉淀试验研究肝硬化机制。

主要发现

  • 小鼠肝细胞MCRS1缺失调节胆汁酸转运蛋白表达,其中Na+-牛磺胆酸共转运多肽(NTCP)显著下调,使胆汁酸在肝窦聚集,并通过在人和小鼠肝星状细胞中主要表达的FXR激活肝星状细胞。
  • 小鼠重新表达NTCP可减轻肝硬化,肝星状细胞中FXR基因消融可抑制小鼠和体外细胞培养中的纤维化标志。
  • MCRS1中推定的SANT结构域缺失使组蛋白去乙酰化酶1从组蛋白H3锚定位点脱离,增加胆汁酸转运蛋白基因的组蛋白乙酰化,调节其表达并扰乱胆汁酸流。
  • 人肝硬化显示核MCRS1和NTCP表达降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Owing to the lack of genetic animal models that adequately recreate key clinical characteristics of cirrhosis, the molecular pathogenesis of cirrhosis has been poorly characterized, and treatments remain limited. Hence, we aimed to better elucidate the pathological mechanisms of cirrhosis using a novel murine model. METHODS: We report on the first murine genetic model mimicking human cirrhosis induced by hepatocyte-specific elimination of microspherule protein 1 (MCRS1), a member of non-specific lethal (NSL) and INO80 chromatin-modifier complexes. Using this genetic tool with other mouse models, cell culture and human samples, combined with quantitative proteomics, single nuclei/cell RNA sequencing and chromatin immunoprecipitation assays, we investigated mechanisms of cirrhosis. RESULTS: MCRS1 loss in mouse hepatocytes modulates the expression of bile acid (BA) transporters - with a pronounced downregulation of Na+-taurocholate cotransporting polypeptide (NTCP) - concentrating BAs in sinusoids and thereby activating hepatic stellate cells (HSCs) via the farnesoid X receptor (FXR), which is predominantly expressed in human and mouse HSCs. Consistently, re-expression of NTCP in mice reduces cirrhosis, and genetic ablation of FXR in HSCs suppresses fibrotic marks in mice and in vitro cell culture. Mechanistically, deletion of a putative SANT domain from MCRS1 evicts histone deacetylase 1 from its histone H3 anchoring sites, increasing histone acetylation of BA transporter genes, modulating their expression and perturbing BA flow. Accordingly, human cirrhosis displays decreased nuclear MCRS1 and NTCP expression. CONCLUSIONS: Our data reveal a previously unrecognized function of MCRS1 as a critical histone acetylation regulator, maintaining gene expression and liver homeostasis. MCRS1 loss induces acetylation of BA transporter genes, perturbation of BA flow, and consequently, FXR activation in HSCs. This axis represents a central and universal signaling event in cirrhosis, which has significant implications for cirrhosis treatment. LAY SUMMARY: By genetic ablation of MCRS1 in mouse hepatocytes, we generate the first genetic mouse model of cirrhosis that recapitulates human features. Herein, we demonstrate that the activation of the bile acid/FXR axis in liver fibroblasts is key in cirrhosis development.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Garrido A, Kim E, Teijeiro A, et al. Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis. J Hepatol. 2021. PMID: 34958836. doi:10.1016/j.jhep.2021.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。